Attenuation of neurodegeneration-relevant modifications of brain proteins by dietary soy

BioFactors

Volumn 12, Issue 1-4, 2000, Pages 243-250

  Kim, H ^a   Xia, H ^a   Li, L ^a   Gewin, J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; ESTROGEN; GENISTEIN; ISOFLAVONE; SOYBEAN PROTEIN;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; DIET; DRUG MECHANISM; ESTROGEN ACTIVITY; ESTROGEN THERAPY; HUMAN; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK; SOYBEAN;

ANIMALIA; GLYCINE MAX; MAMMALIA; PRIMATES;

EID: 0034490833     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520120137     Document Type: Conference Paper

References (51)

1. Phyto-estrogens and western diseases
2. Genistein, a specific inhibitor of tyrosine specific protein kinases
3. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys
4. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer
5. Isoflavones and cancer: The estrogen paradox
6. Gender differences in cognitive function with age: The Rancho Bernardo study
7. Estrogen and the developing mammalian brain
8. The distribution of tau in the mammalian central nervous system
9. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats
10. Chlorination and nitration of isoflavones
11. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
12. The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy
13. Genistein, a component of soy, inhibits the expression of the EGF and ErbB/Neu receptors in the rat dorsolateral prostate
14. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
15. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
16. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry
17. Depletion of acetylated alpha tubulin during microtubule purification from bovine brain gray and white matter regions
18. Mechanisms of action of the soy isoflavone genistein: Emerging role of its effects through transforming growth factor beta signaling pathways
19. Epitopes that span the tau molecule are shared with paired helical filaments
20. Cloning of a novel receptor expressed in rat prostate and ovary
21. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
22. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
23. Correlation between structural transformation and cleavage of the major head protein of T4 bacteriophage
24. Genistein: Chemoprevention, in vivo mechanisms of action, and bioavailibility
25. Estrogen replacement therapy and cognitive decline in older community women
26. Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system
27. The role of soy products in reducing risks of certain cancers
28. Evidence-based medicine and osteoporosis: A comparison of fracture risk reduction data from osteoporosis randomised clinical trials; a review
29. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations
30. Soy, estradiol, and cognitive function: Effects on biomarkers and learning/memory performance of estrogen deficient rats
31. Genistein inhibits both estrogen and growth factor stimulation of transformed human mammary epithelial cell proliferation
32. Osteoporosis: Current approaches and future prospects in diagnosis, pathogenesis, and management; a review
33. Oestrogens and the heart, a review
34. Phytoestrogen kaempferol (3,4′,5,7 tetrahydroxyflavone) protects PC12 and T47D cells from beta amyloid-induced toxicity
35. Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells
36. Dietary isoflavones: Biological effects and relevance to human health, a review
37. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
38. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia
39. Tau protein pathology in neurodegenerative diseases
40. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women
41. Activation of tau protein kinase 1/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons
42. Effects of oestrogen during menopause on risk and age at onset of Alzheimer's disease
43. Novel mechanisms of estrogen action in the brain: New players in an old story, a review
44. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
45. The tangled biology of tau
46. Intracellular APP processing and A-beta production in Alzheimer disease, a review
47. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides
48. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
49. The prevalence of dementia and Alzheimer's, disease in Shanghai, China: Impact of age, gender, and education